Establishment of a specific serum proteomic profile model of nasopharyngeal carcinoma by MALDI-TOF MS

Chinese Journal of Oncology

Volumn 33, Issue 3, 2011, Pages 188-191

  Tao, Ya Lan ^a   Liu, Zhi Gang ^a   Xia, Yun Fei ^a   Yi, Wei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Blood proteins; Differential diagnosis; MALDI TOF MS; Nasopharyngeal neoplasms; Peptides

Indexed keywords

PEPTIDE DERIVATIVE;

ARTICLE; CANCER DIAGNOSIS; COMPUTER PROGRAM; CONTROLLED STUDY; GENETIC ALGORITHM; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NASOPHARYNX CARCINOMA; PEPTIDE ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; BLOOD PROTEINS; HUMANS; NASOPHARYNGEAL NEOPLASMS; PEPTIDE MAPPING; PROTEOME; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 80053404360     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2011.03.008     Document Type: Article

References (13)

1. Villanueva J, Shaffer DR, Philip J, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest, 2006, 116:271-284. (Pubitemid 43121812)
2. Ketterlinus R, Hsieh SY, Teng SH, et al. Fishing for biomarkers: analyzing mass spectrometry data with the new ClinPro Tools software. Biotechniques, 2005, Suppl:37-40.
3. Jeffries NO. Performance of a genetic algorithm for mass spectrometry proteomics. BMC Bioinformatics, 2004, 5:180.
4. Chen YD, Zheng S, Yu JK, et al. Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res, 2004, 10:8380-8385. (Pubitemid 40053400)
5. Tan EL, Looi LM, Sam CK. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma. Singapore Med J, 2006, 47:803-807. (Pubitemid 44378780)
6. Kalpoe JS, Dekker PB, van Krieken JH, et al. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area. J Clin Pathol, 2006, 59:537-541.
7. Li F, Guan Y, Chen Z. Proteomics in nasopharyngeal carcinoma. Cell Mol Life Sci, 2008, 65:1007-1012.